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of vertebroneurology. The patient complained of weakness, numbness,
freezing, of both hands' especially of the right hand, and pain in the back
of the head. Neurological examination showed: converging strabismus
(strabismus convergms). No tendon reflexes in the right hand, in the left
hand (+) positive. Patellar and Achilles reflexes are more elevated. The
patient cannot move the right hand and there are weak flexible movements
of III finger and right shoulder. There is the muscular atrophy of the right
shoulder and the whole right hand. Taking hand up in the air is limited, the
power ofpalm ofthe hand is weaken. There contractures in the joint of the
both shoulders. The neck's movement to the lift ant to the right sides are
limited. Hypesthesia in the both hands in the of C5 and C6 nervous root
projection. No pathologic reflexes noticed. The skin is cyanotic and rough in
the right hand.
Treatment: Pentoxityllinum, Vitamins B12, B6, Neostigmin, physiother-
apy, kinesitherapy.
Conclusions: Tick - born encephalitis is rear disease, but still it gives to know
about itsdf. It causes severe health problems and complications. and treat-
ment not always is successful.
IWeP212! Morbility and prophylaxis tick-borne encephalitis
(TBE) among children in Kaunas District Uthuania
V. MaCioniene, R. MaCionis, S. Panavas
Hospital of Infectious Diseases Kaunas, Lithuania
Ojectives: To analize TBE clinical forms and the rate of vaccination against
TBE among children in Kaunas district.
Methods: The epidemiological, clinical characteristics and laboratory con-
firmation of all TBE patients that have been treated for TBE in Kaunas
Hospital ofinfectious Diseases were analized for the five years period (1995-
1999).
Results: There have been diagnosed 70 cases ofTBE. Tick bites and the use
ofinfected milk (row goats' or caws') havc takcn placc cven in the 78.5% of
all cases. The alimentary route of infection prevailed in family cases. There
were 63.7% ofgirls and 36.3% boys, prevailing age 3-15 years. Among the
clinical manifestation of disease the headacke (91.8%), weakness (93.4%),
vomiting (86.5%), increased temperature (100%) were most frequent. The
fever was two waved in 52.3% ofcases. More frequent clinical forms were
meningitis (72.4%) and meningoencephalitis (18.2%). The diagnosis was
confirmed for all the patients by detecting TBE IgM antibodies in sera. 3021
children have been vaccinated against TBE using BAXTER-IMMUNO
vaccine.
Condusions: I. TBE is a problem of great significance for adults and
children in Lithuania.
2. The only prophylaxis measure against TBE is vaccination using
(BAXTER-IMMUNO) vaccine.
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IWeP213I Nontoxigenic sorbitol-fermenting Escherichia coli
0157:W2 associated with a family outbreak
F. Allerbergerl , U. Gmber-Moesenbacher2, G. Hartmann2, H. TschapeJ.
H. Karch4
tBundesst. Bakt.-Serol. Untersuchungsamtalt, Innsbruck; 2Krankmhaus
FelJkirchAustria; JRobert Koch-Institut, WernigeroJe; 4Institutftir Hygiene unJ
Mikrobiologie, Wjjrzburg, Germany
Objectives: Characterization of 6 sorbitol-fermenting E. coli 0157:H-
isolates that do not contain Shiga toxin genes.
Results: Isolates originated from an outbreak (3 patients, 3 asymptomatic
contacts) of non-bloody diatthea affecting two families sharing one house-
hold. Two children (age 10 months and 2 years) suffered severe diatthea over
30 and 10 days, respectively. Their uncle had moderate diatthea, for 2 weeks.
Contrarily to the other isolates, the uncle's strata did not harbor a chromo-
somal eae gene and not the plasmid gene E-hly; it also showed a PFGE
pattern which was different from the unique pattern of the other isolates.
Employing PFGE, Iysotyping, and P-gene ryping, five of these six [stx
negative!) isolates were indistinguishable from the [stable stx 2 positive!]
"Bavarian outbrcak .train". The only human serum tested, obtained from
one asymptomatic contact. contained antibodies to the 0157 lipopolysac-
caride antigen.
Conclusions: Our finding of five sorbitol-fermenting E. coli 0157:H-
isolates harboring eaeA and E-hly associated with an outbreak of non-
bloody diarrhea .upport. the hypothesis, that Stx may not necessarily be
produced by E. coli 0157 stratus associated with human disease. Whether the
Austrian stx negative clone is an ancestor of or a successor to the Bavarian
clone remains unanswered.
IWeP214IResistance to third generation cephalosporins
remains low in dinical isolates of Klebsiella pneumoniae and
Escherichia coli in the Netherlands
W. Goettsch, A. J. de Neeling
RIVM Bil/hoven, Ne/herlands
Objectives: To study resistance to third generation cephalosporins in
Klebsiella pneumoniae and Escherichia coli.
Methods: In ongoing surveillance of routine samples in seven Dutch
laboratories (Arnhem, Enschede, Haarlem, Heerlen, Leeuwarden, Nijme-
gen, Tilburg), resistance to third generation cephalosporins (cefotaximc or
ceftazidime) was investigated in 65,000 E. coli and 11,000 K. pneumoniae
hospital isolates.
ResuIts: Resistance to these compounds remained low; from 0.2% in 1989
to 0.7% in 1999 in E. coli and from 1.1 % in 1989 to 1.6% in 1999 in K.
pneumoniae. When the resistant strains were studied in more detail, it became
clear that these strains were often multi-resistant: Next to high resistance
against co-trimoxazole (30-40%), especially K. pneumoniae was also fre-
quently resistant against gentamicin (> 20%). Most alarming however, was
the increasing resistance against ciprofloxacin. Especially in K. pneumoniae
f1uoroquinolone resistance increased from 0% (1989-1996) up to 20% in
1999. We did not find any resistance against carbapenems (imipenem).
Conclusions: The production ofbeta-Iactamases in K. pneumoniae and E. coli
is still at a low level and that most infections with these pathogens can still be
treated with the help of (third generation) cephalosporins. Nevertheless,
there are indications that. when an occasional outbreak with cephalosporin
resistant K. pneumoniae occurs, treatment opportunities become more
limited.
IWeP21S1 Oinical and bacteriological characterization of
Actinobacillus homlnls, a new pathogen In immunosuppressed
patients
A. Friis-Mollerl ,].]. Christensen2, V. Fussing2, B. Bruun2
l Depts ofClin. Microbiology H:S HviJovre Hospital; 2Statens Serum lnstitut,
Copenha)len, Denmark
0bjectIYes: The aim of this study was to give clinical data of patients
infected with Actinobacillus hDminis, a rarely recognized pathogen from the
family Pasteureltaceae, and to characterize the bacterium pheno- and geno-
rypically.
Methods: A retrospective study was performed on 38 patients from
Copenhagen with A. hominis isolated from lower respiratory specimens,
pleural fluid and from blood. These isolates and 6 isolates from other
countries, together with 20 strains (including type strains) of related
Pasteureltaceae taxa, were characterized conventionally, and by the ID32
and Vitek automatic identification systems, as well as by riboryping and by
DNA-DNA hybridization.
Results and: conclusions: The role of A. hominis as a human pathogen in
patients with severe immunosuppression and chronic lung disease was
demonstrated. Conventional bacteriological characterization and ribotyp-
ing showed a very homogeneous species, distinct from related Pasteureltaceae
taxa. Identification by the ID32 and Vitek systems was not possible, as these
systems inter alia do not contain this species in their databases. DNA-DNA
hybridization also demonstrated a well circumscribed and homogeneous
species.
IWeP216I Persistent abdominal pain caused by Leptospira
Interrogans
M. Dalamaga, A. Kostoula, C. Chavelas, A. Matekovits, G. Antoniades
Microbiology Department. Ioannina University Hospital, 45 110 Ioannina,
Greece
Objective: To point out the possible diagnosis of Leptospirosis in patients
with persistent abdominal pain.
Methods and MaterIals: We report a case of a white man, 21 years old,
performing his military service, who presented at the Emergency Unit of
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loannina University Hospital, complaining of nausea and strong, persistent
abdominal pain for the last three days. He was admitted to the hospital and
was submitted to a thorough clinical examination, concluding that there was
no need for surgical intervention. Later on the pain localized in the umbilical
region and the patient mentioned strong headache and perspiration. Nuchal
rigidity was noticed on reexamination. The diagnosis of leptospirosis was
confirmed by increasing IgM antibody titers against Leptospira interrogans,
using the ELISA immunosorbent test (BIOS). The patient received tetra-
cycline 2 g per os for 15 days and recovered without any complication
completely.
Conclusion: This case report aims at pointing out the need of taking into
consideration the possibility of Leptospira infection in the differential
diagnosis of persistent abdominal pain. A high level of awareness and
appropriate laboratory studies should allow early diagnosis and may prevent
unnecessary surgical intervention.
[WeP2771 Pneumococcus in the North American Arctic
A. Bell', M. Lovgren2, 1. P.Jette3, A. Reasonover!, A. J. Parkinson'
The ICS Working Group; Arctic Inv"tigations Program, NCID, CDC,
Anchorage, Alaska, United States; 2National Centre for Streptococcus,
Edmonton; 3Laboratoire de Sante Publique du Quebec, Montreal, Canada
Objectives: Initiate prospective population-based invasive pneumococcal
disease surveillance among Arctic nations; describe epidemiologic factors for
aboriginal and non-aboriginal people; characterize serotype and antimicro-
bial resistance (AMR).
Methods: International Circumpolar Surveillance (ICS) began January 1,
1999, and targeted invasive Streptococcus pneumoniae (Sp) among residents of
northern Canada and Alaska. Isolates are from all 23 labs in Alaska, and 14
labs serving northern Canada. Sp isolates are serotyped and tested for AMR
at reference labs in Alaska and Canada. Demographic and clinical informa-
tion are gathered by public health personnel.
Results: (Provisional) In 1999, 152 invasive cases (20.3/100,000) of Sp from
Alaska (N = 120) and northern Canada (N = 32) were sent to ICS by
participating labs. Age range was < 1 to 97 years. Children < 2 comprised
27.6% ofall cases: of these, 90% from Alaska and only 40% from northern
Canada were serotypes contained in the 7-valent conjugate vaccines. In cases
~ 2 years old, 85% were serotypes in the 23-valent vaccine. Incidence is high
in Alaska Natives compared with non-Natives (Canadian data pending).
Serotypes in descending frequency were 14, 7F, 6B and 9V in Alaska, and 1,
4. 14. and 6A in northern Canada. Penicillin non-susceptibility was seen in
20.6% of Alaskan and 6.9% ofnorthern Canadian isolates.
Conduslons: Surveillance of invasive Sp across Arctic North America is
feasible. Although the number of cases from northern Canada is small, the
prevalence of non-susceptible isolates appears low and the proportion of
serotype 1 is unexpected.
IWeP278I Emergence of antimicrobial resistence of
Hemophilus influenzae in a Norhtem Italian area
M. Libanore, M. R. Rossi', F. Pedna l , E. Prini, R. Bicocchi, F. GhineIli
Department of Infectious Diseases; 'Microbiology Unit, St Anna Hospital
Ferrara, Italy
Objective: to evaluate the antibiotic resistance of Hemophilus influenzae
(HI) strains isolated in Ferrara area and to compare these data with Italian
ones in search of a rational therapy for upper and lower respiratory tract
infections.
Material methods: between 1st January 1996 and 31st December 199 a
total of 1024 specimens of respiratory tract were obtained from patients
admitted to St Anna Hospital-Ferrara. Sputum and BAL were cultured on
chocolate agar. Isolated strains were confirmed as HI by using conventional
criteria (API System Bio Merieux). Antibiotic susceptibility and beta-
lactamase production were assayed by Sceptor System and Bio Merieux
method.
Results: a total of 55 strains of HI were characterized in this study. Beta-
lactamase production was 11 % (1996), 6% (1997), 8% (1998) and 5.8%
(1999) respectively. National surveillance data reported 5.2% in 1996 and
12.2% in 1997 of HI beta-Iacramase ptoduction. Rate of resistance to
antibiotics of HI is reported in the table.
Antibiotics 1996 1997 1998 1999
Amoxicillin 23 0 24 6
Amoxi/clavul. 23 0 8 0
CAF 0 0 8 0
Cefaclor 23 19 23 6
Cefotaxime 12 0 0 0
Cefuroxime 12 0 0 0
Erythromycin 100 100 100 100
Gent.mycin 34 25 55 36
PeII.cin 0 0 18 0
Conclusions: monitoring ofthe antibiotic resistance ofHI it is important for
empirical antimicrobial therapy of respiratory infections.
IWeP279! Epidemiology and antibiotic resistance of dlnlQlI
isolates of Moraxella catarrhalis
M. Libanore, M. R. Rossi', E. Prini, F. Pedna l , A. De Carlo, F. Ghinelli
Dept,J of Infectious Disease; 1Microbiology 5t Anna Hospil4l Ferrara, Italy
Objective: antibiotic resistance to the common tespiratory tract pathogens is
increasing worldwide. M. catarrhalis (Me) is a normal inhabitant of the
orophatynx. While this pathogen is rarely revolved in community acquired
pneumonia (CAP), it is more frequently responsable for acute sinusitis, otitis
media or exacerbation ofchronic bronchitis. The objective ofthis study is to
evaluate the epidemiology and antibiotic resistance ofMC strains isolated in
Ferrara in patients with upper and lower respiratory tract infections.
Materials and methods: from January 1996 to December 1999 a total of
1024 specimens were cultured with standard procedures. Antibiotic suscept-
ibility and beta-lacramase production were assayed by Sceptor System and
Bio Merieux method.
RII5UIts: in this study a total of28 strains ofMC were isolated and tested for
antibiotic susceptibility. Beta-Iactamasc productions was observed in 28%
1997 against 57.4% in Italy, 71% (1998) and 84.5% in National Surveillance.
In the table antibiotic susceptibility was reported:
Antibiotic 1996 1997 1998 1999
Amoxicillin 33 28 28 45
Amoxi/c1.vul. 100 100 100 100
Pellox.cin 100 100 100 100
Ccfotaxime 100 100 100 100
Cotrimoxazole 0 0 0 0
Cefuroxime M 71 42 81
Cef.clor 100 100 55 100
Condusion: according to the present data it is possible to develop rational
therapeutical approach to the common respiratory pathogen. Third gen-
eration cephalosporins, fluorquinolones and amoxicillin-clavulanate should
be used in the thetapy of this infection.
IWeP280IClindamydn in Streptococcal Toxic Shock Syndrome
(STSS)
A. Sametl , J. Komamica I, J. ]uszczyk2, A. Gladysz3
'Dept. ofClinical Bacteriology, Public Hospital No 1, Gdansk; 2Dept. of Inf
Dis., Univ. School ofMedicine in Poznan, Poznan; 3 Dept. and Clinic ofInf
Dis. Medical Academy in Wroc1aw, Poland
Objectives: Clinical characteristics and significance of clindamycin treat-
ment of five patients with invasive S. pyogenes infections.
Methods: The diagnosis ofstreptococcal cellulitis was made on the basis of
the following clinical features: diffuse erythema, bulle on the skin, increasing
pain at the site ofinfection and skin necrosis. TSS was diagnosed on the basis
ofCDC criteria. S. pyogenes and copathogens were isolated from surgically
collected tissue samples and subcutaneous needle aspiration. Blood cultures
were negative.
ResuJts: Five adult patients (4 male and 1 female) were hospitalised in
different surgical wards in one tertiary and two regional hospitals. All of the
patients had small local lesions at the beginning: abrasion ofthe skin (3),little
scalp contusion (1) and nail injury (1), but infection quickly progressed. In
three patients skin necrosis and myositis required surgical debridement. All
patients had TSS with hypotension, renal failure, respiratory failure, eon-
fiuion, fever and leucocytosis. S. pyogenes was obtained in monoculture in
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three cases, in onc patient mixed culture with S. aureus, in one with S. aureus
and K. pneumoniae. Three patients were treated with penicillin without
clinical succes. Finally, all were treated with clindamycin: 900 mg/day (1
patient), lBOO mg/day (2), 2700 mg/day (2). Four patients were cured and
one female died ofcirculatory arrest in 13. day ofhospitalisatioD despite local
improvement.
Conclusion: We found clindamycin as first-line drug in invasive S. pyo-
genes infections. It should be ordered in case ofSTSS in high doses from 1800
to 2700 mg/day or above.
IWeP281I First case of meningitis due to penidllin-resistant
Streptococcus pneumonlae (PRSP). In Greece
S. Pentea, S. Kanavaki, S. Karabela, M. Macarona, S. Eustathiou, A.
Pefanis
3rd Department ofMedicine, Athens University MedKal Sthool; Microbiology
D~parl~mmt, "Sotiria" Gmnal Hospital, Ath~ns, Grcec~
ObjectIves: To present the first adult case of meningitis due to PRSP in
Greece.
The case: A 74-year old female patient, with a previous history of non-
Hodgkin's lymphoma, was admitted to the hospital because of fever,
headache and vomiting started 24 hours before admission. PRSP was
isolated from cultures of both CSF and blood. The MICs of the PRSP
strain were as follows: penicillin > 2 IJg/mJ, cefuiaxone > 1 J-tg/mJ,
cefotaxime > 2 IJg/ml, chloramphenicol < 2 lJg/ml, imipenem < 0.06
IJg/ml, and vancomycin < 1 J-tg/ml (Vitec II, bioMerieux, France). By using
the E-test method, the MIC of penicillin was found to be > 3 IJg/ml.
Despite the fact, empirical treatment with ceftriaxone (2 g x 2, iv),
vancomycin (1 g x 2, iv), rifabin (600 mg x I, iv), and dexamethasone (0.4
mg/kg x 2, iv) was started immediately, the patient died one week after
admission to the hospital.
Conclusions: Although, the incidence of infections due to PRSP in some
European countries is high, it still remains quite low in Greece. The isolation
from CSF, for the first time, of a PRSP strain, warrants a change in the
recommended empirical treatment regimen for adult meningitis. The
addition of rifabin or vancomycin to ceftriaxone seems to be a reasonable
choice for adult patients with 0 a Gram-stain of CSF indicative for S.
pneumonia~.
IWeP282I Extraintestinal amoebiasis - An emerging parasitic
infection
Manuela Curescu
Clinic of Infectious Dis~as~s, Univmity ofM~dici~ and Pharmacy Timisoara,
Romania
Objectives: Clinical presentation ofextraintestinal amoebiases, with several
pulmonar abscesses and splenic abscess.
Methods: The author presents the clinical case of the patient M.P., 56 years,
from the district of Arad, Romania, with the following symptoms of
disease: abrupt onset with shivering and septic fever, cough with muco-
Topic 13 - Pharmacokinetics and pharmacodynam
0:13 - Pharmacokinetics and pharmacodynamics of
antimicrobials
IMo0201 AUCIMIC bl'llakpoints of rnoxifloxadn (MOX)
...Iative to levofloxacln (LEV) predicted with in vitro dynamic
models: Single dose versus multiple dose simulations
A. Firsovt, S. Zinner2, S. Vostrovl , I. Lubenkol
'Cmtr~for Science & T~chnology LeItBioT~ch, Moscow, Russian Federation;
ZMount Auburn Hospital, Harvard Medical School, Cambridg~, MA, Unit~d
States
Objectives: To elucidate if single dose pharmacokinetic simulations can
establish AUC/MIC breakpoints.
Methods: The pharmacodynamics of MOX and LEV were studied by
simulating their single and multiple (once-daily dosing for three days) dose
administration. With both single and multiple dosing, a methicillin-resistant
purulent expectoration and, occasionally hemoptysia, wasting syndrome (15
kg weight loss), respiratory impairment and toxemia. The radiologic
examination shows several opacities with large dimensions in both lungs.
After antibiotic therapy with third generation ofcephalosporins, the clinical
signs and the radiologic aspects are unmodified. The performed bronho-
scopy is followed in few hours by vomica with discharging of brown.
chocolate-like pus. The native microscopical examination of the bronchial
aspirate and of the expectoration shows extremely frequent clusters of
vegetative, magna forms, ofEntamoeba histolytica. Abdominal echography
and computertomography confirme the presence of a splenic abscess, with-
out involving the liver and the central nervous system. There were either
epidemiologic argumentations nor other cases ofinfections with Entamoeba
histolytica in the teritory.
Results: After two cures of treatment with the combination hidroxiclor-
oquine + metronidazole, the author succeeded the sterilization of the
pulmonar abscesses with the tendency of normalization of the radiologic
aspect and the disparition of the splenic abscess.
Conclusions: Extraintestinal amoebiases is nowadays not only a tropical
disease and physicians can be confronted with diagnose difficulties, if a
singular case appears in Central Europe.
IWeP283! Rapid progression of medically controlled ce...br.1
cystic echinococcosis
S. Reuter, P. Kern
S~ction ofInf~ctiousDis~ases, University Hospital of Ulm, Gumany
Objectives: We present a rapidly progredient case of cystic cerebral echi-
nococcosis of the brain under current medication with albendazole.
Methods: The patient had been followed in our outpatient department for
more than 5 years. He had been first operated in 1993 and had not been
treated with benzimidazoles postoperatively. In 1996 he was reoperated due
to a relapse and had been on continuous albendazole-treatment since.
Results: He now presented with headaches, adynamy, right-sided
exophthalmos and a fistula in the area of the right eyebrow.
A CCT during a routine visit 4 weeks earlier had been inconspicuous and
he now had two new hypodense structures of6 x 4 cm and 1.5 x 1 em in the
right frontal hemisphere with thin, ringlike contrast enhancement. Histol-
ogy revealed the typical germinal layer of Echillococcus granulosus with no
signs of bacterial superinfection. .
Both structures were resected without opening. Postoperatively, alben-
dazole treatment (BOO mg/d) was complemented by praziquantel (750 mgJ
d). Despite a large operative defect the neurologic symptoms completely
normalized over the next six months.
Conclusions: Postoperative medical treatment in cystic echinococcosis is
generally restricted to 3 months and is usually parasitocidal. In the present
case, long-term treatment was initiated after a relapse 3 years ago. Despite
coverage with benzimidazoles the patient now developed another relapse.
Compliance was reliable and we may assume that either cerebral drug levels
were insufficient to kill the parasite or that prolonged treatment promoted
drug-resistance. As a therapeutic alternative to benzimidazoles praziquantel
was started and has been well tolerated for 5 months.
isolate ofStaphylococcus aureus (MICMOX 0.37 J-tg/ml and MICLEV 0.61J8/
mJ) was exposed to monoexponentially decreasing concentrations ofMOX
and LEV with the half-lives of12 and 6.8 h, respectively, over a 4-fold dose/
MIC ranges that provided the AUC/MIC ratios from 120 to 500 h.
Results: The total antimicrobial effect as expressed by the IE parameter
correlated well with log AUC/MIC (single dose experiments) and mean log
AUC/MIC determined over the 24 h dosing interval (AUC24 h/MIC -
multiple dose experiments) in a quinolone specific fashion. A given AUC/
MIC or AUC24 h/MIC ratio of MOX produced greater IEs than LEV. In
single dose studies, the AUC/MIC breakpoints of MOX and LEV, (the
AUC/MICs that are equivalent to 125-h AUC/MIC of ciprofloxacin) were
80 and 130 h, respectively. The latter value correspond. to a LEV AUC24 hI
MIC of120. In multiple dose studies, this AUC24 h/MIC was equivalent to
6O-h AUC24 h/MIC ofMOX that is equivalent to 8O-h AUC/MIC. Thus,
the AUC/MIC breakpoints of MOX relative to LEV established in single
and multiple dose experiments were almost identical (SO h).
